Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Ther Adv Respir Dis ; 3(5): 227-33, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19736295

RESUMEN

BACKGROUND: Review of the literature suggests that anxiety is more common among patients with asthma than among the general population, yet it does not appear to be given the attention it deserves as part of the overall management of asthma. The aim of this study was to investigate the relationship between anxiety and asthma management, in terms of Global Initiative for Asthma steps, lung function and medication. METHODS: A total of 201 consecutive patients with respiratory physician-diagnosed asthma were recruited from an adult outpatient asthma clinic. Participants underwent a sociodemographic review, and a medical interview which included a detailed drug history. Forced expiratory volume in 1 second (FEV(1)) and peak expiratory flow (PEF) values were recorded using a Micro Medical((R)) portable spirometer. The level of anxiety was assessed using the Beck Anxiety Inventory (BAI). RESULTS: A total of 51.5% of participants registered clinically significant levels of anxiety. Of these only 21% had already been diagnosed and were receiving treatment. Females reported significantly higher BAI scores than males (p < 0.01). More females (66.3%) registered clinically significant levels of anxiety as compared with males (33.7%) (p < 0.05). There was a positive correlation between the BAI score and the prescribed dose of inhaled glucocorticoids (r(s) = 0.150, p < 0.05) and between anxiety and GINA treatment step (r(s) = 0.139, p < 0.05). There was also a positive correlation between anxiety and the number of medicines taken by patients (r(s) = 0.259, p < 0.001). CONCLUSIONS: Physicians treating patients with asthma should be sensitised to the association between asthma and anxiety, and should also consider assessing patients for the possibility of anxiety disorders as part of asthma management plans.


Asunto(s)
Ansiedad/complicaciones , Asma/complicaciones , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Instituciones de Atención Ambulatoria , Ansiolíticos/uso terapéutico , Antiasmáticos/uso terapéutico , Ansiedad/diagnóstico , Ansiedad/tratamiento farmacológico , Asma/diagnóstico , Asma/tratamiento farmacológico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pruebas de Función Respiratoria , Espirometría , Resultado del Tratamiento , Adulto Joven
2.
Pharm World Sci ; 26(4): 208-13, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15446777

RESUMEN

OBJECTIVE: To compare actual practice to that recommended in asthma guidelines, published in Malta in February 1998, with respect to the management of asthma. These were the first national clinical guidelines to be published locally. METHOD: A piloted, structured interview was conducted with patients between 14-59 years who were hospitalised with an admission diagnosis of acute asthma. In the case of repeated admissions, only the first interview was considered. All interviews were carried out by either of two clinical pharmacists and lasted about 30 min. The four-year prospective study started in February 1997 (one year before publication of guidelines and aimed at collecting baseline data) and finished in January 2001 (three years after publication of the local guidelines). MAIN OUTCOME MEASURES: Inhaled steroids on admission. Patient partnership: use of a written self-management plan and home peak flow monitoring. Patient compliance with inhaled steroids. RESULTS: 304 patients (68% females; mean population age 33.9 years SD +/- 13.41) were interviewed over the four-year period. The difference in proportions test (Z-test) was used to analyse the data comparing years 2, 3 and 4 with year 1. No statistical differences were found when comparing the groups for inhaled steroid treatment on admission or availability of a home peak flow meter. Similarly, no differences were found between groups when comparing compliance with inhaled steroids. A statistically significant increase in availability of a self-management plan was found over the study period (3% in year 1; 1% in year 2; 11% in year 3; 9% in year 4), but the overall use of such plans remains disappointingly low. CONCLUSION: With the exception of an increased use of self-management plans, there appears to be lack of adherence to guidelines with consequent undertreatment of asthma, despite the fact that guidelines were published three years ago. This indicates a need to ensure better dissemination and implementation strategies to promote adherence. It is suggested that the clinical pharmacist is well-placed to promote adherence to guidelines.


Asunto(s)
Asma/tratamiento farmacológico , Pacientes Internos , Cuidados a Largo Plazo/tendencias , Guías de Práctica Clínica como Asunto , Reacción de Fase Aguda/diagnóstico , Reacción de Fase Aguda/etiología , Reacción de Fase Aguda/patología , Administración por Inhalación , Administración Oral , Adolescente , Adulto , Antiasmáticos/administración & dosificación , Antiasmáticos/uso terapéutico , Asma/diagnóstico , Enfermedad Crónica , Femenino , Humanos , Cuidados a Largo Plazo/métodos , Masculino , Malta , Cooperación del Paciente , Estudios Prospectivos , Autocuidado/métodos , Esteroides/administración & dosificación , Esteroides/uso terapéutico , Factores de Tiempo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA